





                                                
 






IMMUNE BIOMARKERS PREDICTING CLINICAL OUTCOMES FOR 





























Table of Contents 
Acknowledgments ........................................................................................................... 4 
List of Abbreviations ........................................................................................................ 5 
Abstract .......................................................................................................................... 7 
CHAPTER 1: introduction .................................................................................................. 9 
1.1 Background ........................................................................................................................ 9 
1.2 The physiological response to trauma ................................................................................. 9 
1.3 Effects of trauma on the Immune system .......................................................................... 12 
1.4 Innate immune response to trauma .................................................................................. 13 
1.4.1 Pro inflammatory responses ............................................................................................................. 13 
1.4.2 The inflammatory cascade ................................................................................................................ 14 
1.4.3 Systemic inflammatory response syndrome .................................................................................... 15 
1.5 Adaptive Immune response .............................................................................................. 15 
1.5.1 Humoral immunity ............................................................................................................................. 15 
1.5.2 T cell mediated immunity .................................................................................................................. 16 
1.6 Generation of T cells ......................................................................................................... 17 
1.7 T cell lineages ................................................................................................................... 19 
1.8 T lymphocyte response to trauma ..................................................................................... 20 
1.8.1 Regulatory T cells ............................................................................................................................... 20 
1.8.2 Markers of regulatory T cells ............................................................................................................. 21 
1.9 Study aims and objectives ................................................................................................ 23 
CHAPTER 2: Materials and methods ................................................................................24 
2.1 Study designs ................................................................................................................... 24 
2.1.1 Patient selection criteria ................................................................................................................... 24 
2.1.2 Data collection time points ............................................................................................................... 24 
2.2 Laboratory methods ......................................................................................................... 25 
2.2.1 Peripheral blood mononuclear cells (PBMC) isolation and cryopreservation ................................ 25 
2.2.2 Retrieval of PBMCs ............................................................................................................................ 25 
2.2.3 PBMC enrichment .............................................................................................................................. 25 
2.2.4 Giemsa staining and microscopy ....................................................................................................... 26 
2.2.5 Immuno-fluorescent staining of T cell surface markers ................................................................... 26 
2.2.6 Staining for FOXP3+ transcription markers ...................................................................................... 26 
2.2.7 Flow cytometry analysis .................................................................................................................... 27 
2.2.8 Gating strategy ................................................................................................................................... 27 
2.3 Statistical analysis ............................................................................................................ 27 
2.3.1 Statistical analysis of early T cell expression and late SOFA scores ................................................ 27 
2.3.2 Statistical analysis of early T cell expression and late grouped SOFA scores.................................. 28 
2.3.3 Statistical analysis of T cell and interleukin expression ................................................................... 28 
CHAPTER 3: Results .........................................................................................................29 
3.1 Trends in T cell subset expression on Day 1, 3, and 5 following traumatic injury. ................ 29 
3.2 Relationships between mean T cell data and SOFA scores.................................................. 30 
3.3 Relationship between mean T cell data and grouped SOFA scores ..................................... 35 
 3 
3.4 Relationship between T cell data and Interleukin 6 (IL-6) and interleukin 10 (IL-10). ........... 40 
CHAPTER 4: Discussion ....................................................................................................44 
4.1 Trends in T lymphocyte expression following traumatic injury ........................................... 45 
4.2 Comparison of early T lymphocyte subsets in relation to late SOFA scores ......................... 45 
4.3 Correlation between T reg cells and IL-6 and IL-10 ............................................................. 48 
4.4 Conclusions ...................................................................................................................... 49 
CHAPTER 5: References ...................................................................................................50 
CHAPTER 6: Appendices ..................................................................................................56 
Appendix 1: Day 1 – Clinical data from Central Manchester Foundation Trust and calculated 
SOFA scores ........................................................................................................................... 56 
Appendix 2: Day 3 – Clinical data from Central Manchester Foundation Trust and calculated 
SOFA scores ........................................................................................................................... 58 
Appendix 3: Day 5 – Clinical data from Central Manchester Foundation Trust and calculated 
SOFA scores ........................................................................................................................... 60 
Appendix 4: Day 1 – Clinical data from Salford Royal Foundation Trust and calculated SOFA 
scores .................................................................................................................................... 62 
Appendix 5: Day 3 – Clinical data from Salford Royal Foundation Trust and calculated SOFA 
scores .................................................................................................................................... 64 
Appendix 6: Day 5 – Clinical data from Salford Royal Foundation Trust and calculated SOFA 
scores .................................................................................................................................... 66 
Appendix 7: Day 1 – T lymphocytes (CD3+, CD4+, CD8+, CD25BRI, CD25BRIFOXP3+, 
CD4+FOXP3+, CD127LOWFOXP3+) concentration and SOFA scores .......................................... 68 
Appendix 8: Day 3 – T lymphocytes (CD3+, CD4+, CD8+, CD25BRI, CD25BRIFOXP3+, 
CD4+FOXP3+, CD127LOWFOXP3+) concentration and SOFA scores .......................................... 70 
Appendix 9: Day 5 – T lymphocytes (CD3+, CD4+, CD8+, CD25BRI, CD25BRIFOXP3+, 
CD4+FOXP3+, CD127LOWFOXP3+) concentration and SOFA scores .......................................... 72 
















I would firstly like to thank my supervisor Prof. Niroshini Nirmalan for the consistent 
support and guidance throughout my research, and academic career. Without her knowledge 
and patience I could not have achieved these results. 
 
 I would also like to acknowledge the contribution of Basmah Allarakia and Matthew 
Jones for the collection of data and laboratory procedures which allowed me to carry out my 
statistical research analysis. 
 
 Finally, my thanks go out to the teams at Central Manchester Foundation Trust and 




























List of Abbreviations  
 
 
AIS Abbreviated injury score  
AMP  Adenosine monophosphate  
APACHE  Acute physiology and chronic health evaluation 
APC Antigen presenting cell  
ATLS Advanced trauma life support  
ATP  Adenosine triphosphate  
BCR B cell receptor  
BP Blood pressure  
cAMP Cyclic adenosine monophosphate  
CARS Counter anti-inflammatory response syndrome  
CD Cluster of differentiation 
CMFT Central Manchester Foundation Trust 
CNS Central nervous system  
CRP  C-reactive protein  
CT Computed tomography 
CTLA-4 Cytotoxic T-lymphocyte associated protein-4 
CVVH/IHD Continuous veno-venous hemofiltration/Intermittent haemodialysis 
DAMPs Damage associated molecular patterns 
DMSO Dimethyl-sulfoxide  
DP Double positive  
eGFR Estimated glomerular filtration rate  
FACS Fluorescence activated cell sorting  
FAST Focused assessment with sonography for trauma 
FCS  Foetal calf serum  
FiO2 Fraction of inspired oxygen 
FOXP3 Forkhead box P3 
FSC Forward scatter  
GCS Glasgow coma score 
GITR Glucocorticoid induced tumour necrosis factor receptor related protein  
GM-CSF Granulocyte macrophage colony-stimulating factor 
Hb Haemoglobin  
HMGB High mobility group box 
HR Heart rate  
ICOS Inducible T-cell co-stimulator  
IDO Indoleamine 2.3-dioxygenase  
IL Interleukin  
INF Interferon  
INF- Interferon gamma  
ISS Injury severity score 
JAK-STAT Janus kinase signal transducer and activator of transcription pathway 
LAG-3 Lymphocyte activating gene 3  
MAP Mean arterial pressure  
 6 
MAPK Mitogen-activated protein kinase 
MHC II Major histocompatibility complex 2 
MODS Multiple organ dysfunction syndrome 
MOF Multiple organ failure  
mRNA Messenger ribonucleic acid 
NFAT Nuclear factor of activated T cells  
NF- Nuclear factor kappa-beta 
NISS New injury severity score 
NIV/CPAP Non-invasive ventilation/Continuous positive airway pressure 
NK Natural killer 
OIS Organ injury scale 
PAMPs Pattern associated molecular patterns 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate buffered saline 
PD-1 Programmed cell death protein 1 
P/F Ratio of arterial oxygen partial pressure to fractional inspired oxygen  
PLT Platelet  
PT Prothrombin time 
RBC Red blood cell 
SIRS Systemic inflammatory response syndrome  
SOFA Sequential organ failure assessment  
SPSS Statistical package for the social sciences  
SRFT Salford Royal Foundation Trust  
SSC Side scatter 
TCR T cell receptor  
TGF Transforming growth factor 
TGF- Transforming growth factor beta 
TH T helper 
TIM-3 T cell immunoglobulin domain and mucin domain  
TLR Toll-like receptor  
TNF Tumour necrosis factor  
TNF- Tumour necrosis factor alpha 
TNFR Tumour necrosis factor receptor  
TRAIL Tumour necrosis factor related apoptosis inducing ligand 
T reg T regulatory cells 










Major trauma continues to be the most common cause of death in the population 
under the age of 40 in England. Despite advances in trauma care in the UK, sepsis and multiple 
organ dysfunction syndrome (MODS) continue to be severe complications of trauma 
worldwide. Ongoing research exploring the immune response to trauma over the years has 
highlighted the systemic inflammatory response syndrome (SIRS) as an early immune 
response to trauma. Driven mainly via macrophages and innate immune cells, this response 
is followed by the counter anti-inflammatory response syndrome (CARS), mediated 
predominantly by T regulatory cells, in order to restore immune homeostasis.  
 
The ‘two-hit theory’ proposes a link between MODS and an imbalance between 
proinflammatory and counter inflammatory responses, during which, an overexpression of 
SIRS results in early MODS and an overexpression of CARS results in late MODS, sepsis or 
septic shock. The suppressive abilities of T reg cells and the role they may play in this immune 
response is an area of great interest as early identification of T reg activity within the CARS 
response may act as a predictive biomarker of late MODS and poor clinical outcome.  
 
This study aims to analyse the trends of 7 subsets of T lymphocytes; CD3+, CD4+, CD8+, 
CD25BRI, CD4+FOXP3+, CD25BRIFOXP3+, and CD127LOWFOXP3+ following major trauma, in 
the hopes of utilizing these as predictive biomarkers in the future of trauma care. Poor clinical 
outcome was represented in this study by a Sequential organ failure assessment (SOFA) score 
of greater than 1. In order to explore the relationship between CD markers, particularly T reg 
cells, and other mediators of inflammation, all CD markers used in this study were also tested 
against  interleukin 6 (IL-6) and IL-10.   
 
Prior to this study, blood samples from a cohort of 85 patients were gathered by 
Basmah Allarakia and Matthew Jones from the Central Manchester Foundation Trust (CMFT) 
and Salford Royal Foundation Trust (SRFT). Laboratory procedures were then carried out by 
Basmah Allarakia, during which, peripheral blood mononuclear cells were isolated, retrieved, 
and enriched. Immunofluorescent staining of T cell surface markers was done using 
fluorochrome labelled antibodies, before finally being analysed using FACS Verse flow 
cytometry.  
 
During this study, T lymphocyte expression was analysed using the SPSS statistical 
software. A Spearman’s rank correlation test highlighted a significant correlation between 
CD3+ expression on Day 1 and SOFA scores on Day 5 (p= 0.007). A significant correlation 
between CD3+, CD25BRIFOXP3+ and CD127LOWFOXP3+ on Day 3 against SOFA scores on Day 
5 was also found (p=0.02, p=0.049 and p=0.048 respectively). Furthermore, a paired T test 
highlighted that CD25BRIFOXP3+ and CD127LOWFOXP3+ displayed higher expression on Day 
1 in those patients who developed SOFA scores >1 on Day 5, in comparison to patients who 
developed SOFA scores <1 on Day 5. These differences were also found to be significant (p= 
0.05 and p= 0.03 respectively). A second Spearman’s rank correlation test also displayed a 
significant correlation between CD3+ and IL-10 on Day 3 (p= 0.000). furthermore, a significant 
correlation between both CD25BRIFOXP3+ and CD127LOWFOXP3+ and IL-6 on Day 3 was also 
found (p= 0.026 and p= 0.029 respectively).  
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Overall, significant findings were displayed regarding the role of T reg cells and their 
ability to be used as predictive biomarkers in the future of trauma care. Correlating to 
previous research, a higher expression of T regs was seen in patients who later developed a 
higher SOFA score, thus a poorer clinical outcome. The suppression mechanisms of T regs 
which may explain these results have been grouped into four main categories, these are; 
metabolic disruption, cytolysis, inhibitory cytokines such as interleukin-35 (IL-35), IL-10, and 
transforming growth factor- (TGF-), and finally, suppression by modulation of dendritic cell 
function or maturation.  
 
The correlation between T regs and IL-6 also provide promising potential for the future 
of biomarker research, however a larger patient cohort and greater statistical analysis of 
these two immune markers must be carried out in order to confirm the validity of these 
































Major trauma remains the most common cause of death in the population under the 
age of 40 in England (Forward et al., 2014), as well as one of the commonest causes of death 
and disability worldwide (Moran et al., 2018). This type of trauma is defined as a life altering 
injury which may involve a single system such as an isolated neck injury, or alternatively a 
severe multiple organ system trauma (Forward et al., 2014). The national audit office 
estimates that there are 5,400 major trauma deaths a year from 20,000 cases (Moran et al., 
2018), with the most common cause being identified as road traffic accidents.  
 
Over the years, much has been done to combat this problem and provide the best 
clinical outcomes, leading to the introduction of 27 designated major trauma centres in the 
UK: 11 for both adults and children, 10 for adults, 5 for children, and 1 collaborative centre 
(Moran et al., 2018). This new system allows patients to receive specialised care immediately, 
in comparison to the previous standards which meant they were sent to the nearest hospital 
irrespective of the severity of the injuries or the ability of the hospital to care for the injury at 
hand (Forward et al., 2014).  
 
A major milestone in trauma care was the introduction of a complex trauma response 
system, which is now considered to be the standard adopted in the majority of countries 
worldwide. Using this system, severely injured patients do not pose a prognostic challenge 
during the early triage stage. However, this process does not work as effectively for patients 
who are initially stable, but whose conditions deteriorate quickly later on. Over the last 
decade, prognostic tools such as severity scores and biomarkers have been developed in 
order to estimate the burden of injuries for these patients in an attempt to predict poor 
clinical outcomes (Salvo et al., 2020). 
 
 
1.2 The physiological response to trauma  
 
In 1983 the distribution of trauma related mortality was described by Trunkey as 
trimodal, consisting of immediate, early and late phase deaths (Table 1.1) (Trunkey, 1983). 
Following many advances in trauma care, this distribution is now assumed to be largely 
bimodal, with a large majority of trauma deaths occurring immediately or during the late 







Table 1.1: Classification of immediate, early and late deaths due to trauma.  
 
Trunkey’s 1983 classification of Immediate, early, and late trauma deaths 




Location Cause Interventions 
Immediate Minutes Scene Nonsurvivable 
injuries 
Injury prevention 
Early Hours Hospital Severe injuries, 
potentially 
survivable with 
optimal care.  
Improved access to 
trauma care 






Table displaying the timings, location, cause and interventions for trauma related deaths. 
Adopted from (Trunkey, 1983).  
 
Stress responses induced by trauma include haemodynamic, metabolic and 
immunological changes, with greater stress resulting in increased reactions. Cytokines and 
hormones play a large role in these responses (Simsek et al., 2014). The haemodynamic 
response represents the patients initial ability to survive (Kirkman & Watts, 2014), whereas 
metabolic pathways are central to the bodies compensatory responses which occur later 
(Krepska et al., 2017).  
 
Since the description of trimodality, several advancements in trauma prevention and 
treatment have been introduced such as advanced trauma life support (ATLS), 
implementations of CT scans and focused assessment with sonography for trauma (FAST), as 
well as developments in intensive care medicine. As a result, an overall reduction in trauma 
mortality has been observed (Rauf et al., 2019). Despite this, sepsis and multiple organ failure 
(MOF) are still severe complications following trauma. Recent studies analysing data from 
78,310 severely injured patients found that the rate of sepsis and MOF among non survivors 
was 11.5% and 70.1% respectively (Rauf et al., 2019). The mean time to death in cases with 
sepsis was also found to be 23.3 days, highlighting the work done in previous studies which 
described sepsis and MOF as the leading causes of death (>1 week) (Baker et al., 1980).  
 
The sequential organ failure assessment (SOFA) score is an objective score which 
allows for the calculation of the number and severity of organ dysfunction in six organ systems 
(liver, coagulation, respiratory, renal, cardiovascular, and neurologic) (Table 1.2), allowing 






Table 1.2: The sequential organ failure assessment (SOFA) score 
 
 SOFA SCORE 
Organ system  1 2 3 4 
Respiration PaO2/FiO2 
(mmHg) 
<400 <300 <220 <100 
Coagulation Platelets 
(x103/mm3) 
<150 <100 <50 <20 
Liver Bilirubin 
(mg/dL) 
1.2-1.9 2.0-5.9 6.0-11.9 >12.0 












CNS GCS 13-14 10-12 6-9 <6 
Renal Creatine 
(mg/dL) 
1.2-1.9 2.0-3.4 3.5-4.9 >5.0 
 
MAP: Arterial pressure 
CNS: Central Nervous system 
GCS: Glasgow coma score  
Adopted from (Grissom et al., 2010) 
 
 
Trauma scores are used to assign numerical values to anatomical lesions and 
physiological changes after injury. Physiological scores describe changes in vital signs and 
consciousness and are often used during first contact with the patient. Physiological scoring 
systems include the revised trauma score, Glasgow trauma score, as well as APACHE scoring 
(acute physiology and chronic health evaluation). Anatomical scores describe all of the 
injuries recorded by imaging, clinical examination, surgery or autopsy. These scores are used 
following a complete diagnosis in order to stratify trauma patients. Anatomical scoring 
systems include the abbreviated injury scale (AIS), injury severity score (ISS), new injury 
severity score (NISS), organ injury scale (OIS) and anatomical profile. The ISS has been 
described as virtually the only anatomical scoring system in use which correlates linearly with 
morbidity, mortality, and hospital stay among other measures of severity. Each injury is 
assigned an AIS score allocated to one of six body regions. The sum of squares of the three 
highest regions will then produce the ISS value. Major trauma is considered when ISS > 15 










1.3 Effects of trauma on the Immune system  
 
Traumatic injuries are responsible for inducing a complex response which disrupts the 
homeostasis present within the immune system. Following the initial response to injury, cells 
of the innate and adaptive immune system produce proinflammatory and counter 
inflammatory responses, referred to as SIRS and CARS in order to restore immune 






Figure 1.1: The ‘two hit theory’ proposes a link between multiple organ dysfunction 
syndrome (MODS) and an imbalance in proinflammatory and counter inflammatory 
immune responses.  
The innate immune system driven systemic inflammatory response syndrome (SIRS) is 
achieved predominantly by macrophages which prime toll-like receptors (TLRs). However, the 
adaptive immune system driven compensatory anti-inflammatory response syndrome (CARS) 
is driven due to priming of regulatory T cells (T reg). If a pro inflammatory reaction is 
overexpressed, the patient may develop a ‘two-hit’ response, leading to multiple organ 
dysfunction (MODS). If the counter anti-inflammatory response is overexpressed, the patient 
will possess an increased risk of developing complications such as late MODS, sepsis, or septic 









1.4 Innate immune response to trauma  
 
The innate immune system is a non-specific system which acts as the first line of 
defence. Major trauma prompts a series of innate immune responses, in the hopes of 
restoring the cells of the body to their pre injury state (Huber-Lang et al., 2018).   
 
Initially, trauma leads to the damage of internal and external barriers which exposes 
the immune system to damage associated molecular patterns (DAMPs) such as HMGB-1 and 
pattern associated molecular patterns (PAMPs). These danger signals are then sensed by 
inflammatory pathways containing lipids and proteins which participate in the first line of 
defence. In particular, the serine protease system, composed of the complement and 
coagulation cascades are activated after trauma and can detect DAMPs and PAMPs (Huber-
Lang et al., 2018).  
 
Either directly or via these systems, DAMPs and PAMPs can transmit their signals to 
leukocytes such as neutrophils and monocytes through pattern recognition receptors (PRRs) 
such as toll like receptors (TLR), complement receptors, or purinergic receptors. The 
activation of these inflammatory cells stimulates the production and release of inflammatory 
mediators such as interleukins, thus generating the response seen in the systemic 
inflammatory response syndrome pathway (Huber-Lang et al., 2018).  
 
The reprioritizing of leukocytes following severe trauma have been described to be 
unique to each injury pattern. The release of micro vesicles from leukocytes also enhances 
adhesion, inflammation, and stimulates activation of the clotting system in order to contain 
haemorrhage. However, following a substantial injury which may be associated with 
extended surgical intervention or haemorrhage shock, the innate immune response may 
become imbalanced (Huber-Lang et al., 2018).  
 
 
1.4.1 Pro inflammatory responses 
 
Pro inflammatory responses develop following trauma in order to protect the host 
from infections via heightening the antimicrobial immunity. Inflammatory stimuli, including 
cytokines such as interleukin-6 (IL-6), interleukin-1 (IL-1), and tumour necrosis factor- 
(TNF-), mediate inflammation through interactions with the Toll like receptors (TLRs), IL-6 
receptor (IL-6R), IL-1 receptor (IL-1R), and TNF receptor (TNFR) (Kaminska, 2005). The 
activation of these receptors triggers signalling pathways which include the nuclear factor 
kappa-B (NF-kB), mitogen-activated protein kinase (MAPK), and Janus kinase signal 
transducer and activator of transcription pathway (JAK-STAT) (Chen et al., 2017). 
 
Following these pathways, cytokines are released from immune cells such as 







Table 1.3: Overview of pro-inflammatory cytokines and their functions. 
 
Cytokine Family Main sources Function 


















killer (NK) cells 







INF- INF T-cells 
NK cells 
NKT cells 
Innate and adaptive 
immunity 









Adapted from (Chen et al., 2017).  
 
 
1.4.2 The inflammatory cascade 
 
Trauma, inflammation or infection leads to the activation of the inflammatory 
cascade. Macrophages, monocytes, mast cells, endothelial cells, and platelets are responsible 
for producing cytokines. Firstly, inerleukin-1 (IL-1) and tissue necrosis factor-alpha (TNF-) 
are released, and initiate several cascades. The release of TNF- and IL-1 result in the cleavage 
of the nuclear factor- (NF-) inhibitor. Following the removal of this inhibitor, NF- 
initiates the production of messenger ribonucleic acid (mRNA), further inducing the 
production of proinflammatory cytokines such as IL-8, IL-6 and interferon gamma (Kaplan, 
2018). 
 
These proinflammatory interleukins activate the complement and coagulation 
cascade as well as the release of prostaglandins, leukotrienes, and nitric oxide. Within the 
complement cascade, protein complements C3a and C5a are responsible for vasodilation, 
increased vascular permeability, and the release of additional cytokines (Kaplan, 2018). 
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1.4.3 Systemic inflammatory response syndrome 
 
The two hit response is one of the serious complications of major trauma. Previous 
research findings by Paterson et al., 2003 have shown that TLR reactivity is enhanced 
following trauma. This suggests that the two hit response may be mediated through 
enhanced TLR reactivity by innate immune cells. These immune cells become increasingly 
reactive to toxins, resulting in high levels of cytokine production which may trigger a 
secondary SIRS response and MODS (Osuka et al., 2014). Excessive pro inflammatory cytokine 
production may lead to haemodynamic changes, tissue damage, organ failure, and death.  
 
A counter inflammatory response acts to compensate for trauma induced 
inflammation. Previous studies have shown major trauma leads to a decreased resistance to 
infections due to CARS (Bone, 1996). Observations from numerous studies suggest that the 
adaptive immune system, particularly T cells, are responsible for mediating this response 




1.5 Adaptive Immune response 
 
Adaptive immunity is characterised on the basis of greater specificity than the innate 
immune response. Lymphocytes are the cells involved in the adaptive immune response and 
possess receptor sites on their cell surfaces. The receptors on each lymphocyte fits with a 
specific antigen on an invader, thus responding to a specific invader. Upon activation of these 
antigen specific cells, a population of cells is created with the same antigen specificity. As this 
process takes up to several days before a fully effective defence is achieved, the host must 
therefore rely on natural immunity during this delay (Segerstrom and Miller, 2004). 
 
Adaptive immunity is composed of cellular and humoral responses. Cellular immunity 
responds against intracellular pathogens such as viruses and are coordinated by a subset of T 
helper (CD4+) lymphocytes called Th1 cells and Cytotoxic T cells (CD8+). Humoral immunity 
responds against extracellular pathogens such as bacteria and parasites and are coordinated 
by a subset of T helper (CD4+) lymphocytes called Th2 cells (Segerstrom & Miller, 2004). 
 
 
1.5.1 Humoral immunity  
 
During the humoral response antibodies are produced by B cells, causing the 
destruction of extracellular pathogens, therefore preventing the spread of intracellular 
infections. Helper T cells are required for the activation of B cells as well as their 
differentiation into antibody secreting plasma cells. During this response, the term helper T 
is used predominantly to describe a subset of CD4 T cells referred to as Th2 (Travers &  
Walport, 2001).  
 
Interactions between antigen specific B cell receptors (BCR) on naïve mature B cells 
and protein antigens result in internalization of the antigen. Following this internalization, the 
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antigen is then processed and presented with major histocompatibility complex II molecules 
(MHC II), which are found on antigen presenting cells such as dendritic cells. The presented 
antigen is then recognised by the T cell receptor of the T helper cells. As well as this, the CD4 
molecule of the T cell interacts with the MHC II on the surface of the B cell.  
 
Following this recognition, a subset of CD4+ T helper cells referred to as Th2 cells will 
produce and secrete cytokines such as IL-4, IL-5, and IL-13. These cytokines are responsible 
for several actions such as the activation of B cells, leading to proliferation into daughter cells. 
Cytokines released by Th2 cells are also responsible for the differentiation of B cell clones into 
memory B cells and plasma cells which will produce antibodies (Marshall et al., 2018). 
 
 
1.5.2 T cell mediated immunity  
 
Once T cells have developed in the thymus, they then enter the bloodstream. Here 
they circulate between peripheral lymphoid tissue and blood until they meet their specific 
antigen. During the cell mediated immune response, T cells differentiate into cytotoxic T cells 
(CD8+) or helper T cells (CD4+) (Marshall et al., 2018). 
 
Helper T cells (CD4+) are activated following the interaction of their TCR with antigen 
bound to MHC II molecules. Unlike the Helper T cell response during humoral immunity, cell 
mediated immunity uses the Th1 subset. The Th1 response leads to the production of IFN- 
which is responsible for the activation of bactericidal activities of macrophages and enhances 
immunity to other intracellular pathogens. Th1 derived cytokines also contribute to the 
differentiation of B cells to produce antibodies responsible for enhancing the efficiency of 
phagocytosis.  
 
Cytotoxic T cells (CD8+) are activated following the interaction of their TCR with 
peptide bound to MHC I molecules. Expansion of CD8+ cells produces effector cells which are 










Figure 1.2: Overview of cells involved in the humoral and cell mediated immune 
responses.  
Adapted from (Marshall et al., 2018).  
 
 
1.6 Generation of T cells  
 
T cells are derived from haematopoietic stem cells, which are found in the bone 
marrow. Following this they migrate and mature in the thymus. These cells express unique 
antigen binding receptors on the surface of their membrane, known as the T cell receptor 
(TCR). Each T cell expresses a specific type of TCR and will eventually proliferate and 
differentiate provided it receives the appropriate signal to do so. The majority of T cells 
develop as  T cells, however 5% express the  T cell receptor. Further on in development, 
the  T cells will develop into the CD4 and CD8 subsets (Marshall et al., 2018).  
 
During the earliest stage of development, the thymocytes will lack expression of both 
CD4 and CD8 receptors, and are therefore described as double negative (DN). This DN 
population is then further divided according to the expression of either an adhesion molecule 
termed CD44, or the interleukin-2 receptor a chain, termed CD25. Cells expressing CD25 and 
lacking CD44 will undergo beta selection, as they are able to produce a pre TCR which is able 
to form a complex with CD3 . This complex results in expression and up regulation of CD4 and 
CD8, creating double positive cells (DP).   
 
DP cells will then arrange their TCR- chain, producing an -TCR. The cells will then 
undergo positive and negative selection. Cells which engage with antigen/MHC with an 
appropriate affinity undergo positive selection in the cortex and survive, whereas those that 
interact with a weaker affinity will die via apoptosis. During positive selection if cells were 
positively selected by MHC class II molecules, the thymocytes are then committed to 
becoming CD4+ cells. Similarly, if cells were positively selected by MHC class I molecules, the 
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thymocytes are then committed to becoming CD8+ cells. Negative selection also takes place 
in the medulla, during which, self-antigens are presented to thymocytes on antigen 
presenting cells (APC) such as macrophages and dendritic cells. Thymocytes which interact 
too strongly with antigens during this process will undergo apoptosis. Following both positive 
and negative selection, down-regulation of either co-receptor will produce either naïve CD8+ 




Figure 1.3: Overview of the pathways involved in the production of T helper cells, 




















1.7 T cell lineages  
 
Several types of T cell lineages exist; T helper cells, cytotoxic T cells, memory T cells, 




Figure 1.4: Overview of lymphocyte lineages. Adapted from (Alegre et al., 2001). 
 
T helper cells (CD4+) have a vital role in maximizing the immune response. Although 
these cells cannot directly kill infected cells, they direct other cells to perform these tasks. 
Several types of T helper cells can be induced such as Th1, Th2, Th17 and T reg. The Th1 
response produces IFN-, leading to the activation of bacterial activities of macrophages as 
well as an immunity to intracellular pathogens. The Th2 response produces cytokines IL-4. IL-
5, and IL-13, which are responsible for the development of antibody producing B cells as well 
as the recruitment of eosinophils and mast cells which are essential for responses against 
parasites.  
Th17 cells are responsible for the production of cytokines of the 1L-17 family which are 
predominantly descried as proinflammatory cells (Marshall et al., 2018).Regulatory T cells (T 
reg) also play a vital role in the immune response as they contribute to the counter 





1.8 T lymphocyte response to trauma  
 
As seen through both the humoral and cell mediated immune responses, T 
lymphocytes play an important role in the immune response to trauma. They are 
distinguished from other lymphocytes such as B cells and NK cells due to the presence of an 
antigen specific molecule on the surface, identified as a T cell receptor (TCR).  
 
Following the initial response to traumatic injury, cells of the innate and adaptive 
immune system initiate the proinflammatory (SIRS) response as well as a counter 
inflammatory response referred to as CARS (Stoecklein et al., 2012). An imbalance between 
these inflammatory immune responses causes heightened susceptibility to infections and 
organ damage (Hefele et al., 2019). The CARS response is initiated in order to suppress trauma 
induced inflammation, control reactivity to damaged tissues, and to restore immune 
homeostasis (Stoecklein et al., 2012). This response is believed to be mediated by the 
adaptive immune system, in particular T cells (Osuka et al., 2014).  
 
The counter inflammatory phase of the injury response is displayed at later time 
points following injury, suggesting it is a developed reaction to the molecular and cellular 
triggers which initiate the injury response. The CARS response has been labelled as an 
immune suppressive response. This is due to the anergic-like properties displayed by T 
mediated responses including: low proliferative responses to specific antigens and mitogens; 
suppressed Th1 type immune reactivity alongside increased Th2 type cytokine production; 
finally increased T reg activity (Stoecklein et al., 2012). A primary complication of the CARS 
response to traumatic injury is that it may actively suppress antimicrobial immunity, thus 
increasing the hosts susceptibility to opportunistic infections which occur during the counter 
inflammatory phase of injury (Osuka et al., 2014).  
 
 
1.8.1 Regulatory T cells  
 
Regulatory T cells are a subset of the thymic derived CD4+ T cells, and have been 
shown to be crucial for the maintenance of immune homeostasis and the regulation of the 
immune system (Okeke & Uzonna, 2019). This unique CD4+ T cell subset constitute 
approximately 5-10% of peripheral CD4+ T cells (Okeke & Uzonna, 2019) and are 
characterised by the expression of the surface interleukin-2 receptor  chain (IL-2R), also 
referred to as cell surface CD25 molecules (CD25) (Safina et al., 2015). The intracellular 
transcription factor, FOXP3 is also known to play a crucial role in the function and 
development of T regs (Safina et al., 2015). Studies have shown that the loss of FOXP3 
expression in T reg cells may affect the competency of these cells acquiring effector T cell 
properties such as the production of cytokines IL-2, IL-4, IL-17, and IFN- (Wan & Flavell, 
2007).   
 
These natural regulatory T cells possess potent suppressive abilities and were initially 
thought to suppress CD4+CD25- T cells. Following T reg depletion, CD4+ Th cells have 
exhibited increased cellular activity, leading to the activation of immune cells, resulting in 
excessive inflammatory response, organ damage, and mortality (Okeke & Uzonna, 2014). 
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However, recently T regs have been recognised in the regulation of other cells within the 
adaptive immune system such as CD8+ T cells and B cells (Okeke & Uzonna, 2019).  
 
The immunosuppressive qualities of T reg cells are expressed through a variety of 
mechanisms including, the production of anti-inflammatory cytokines, modulation of antigen 
presenting cell (APC) function and maturation, disruption of metabolic pathways, and the 
induction of apoptosis in target cells (Safina et al., 2015).   
The ability of T reg cells to produce IL-10 and transforming growth factor-1 also allow 
the suppression of pro inflammatory immune responses (Osuka et al., 2014).  
 
 
Table 1.4 Overview of anti-inflammatory cytokines produced by T reg cells and their 
functions.  
 
Cytokine Family Main sources Function 
IL-10 IL-10 Monocytes 
T cells 
B cells 
Inhibition of the pro-
inflammatory 
cytokines 




cytokine production  




The role of T reg cells in the maintenance of immunity during infection is controversial. 
Many studies indicate that the suppressive nature of regulatory T cells is detrimental to the 
host due to the limited immune response. In the case of sepsis, circulating T regs from trauma 
patients displayed increased T reg cell activity by 5-7 days following injury, in comparison with 
T reg cells from normal individuals or patients at day 1 following injury (MacConmara et al., 
2006). Similarly, septic patients have displayed higher numbers of circulating T regs 
(Monneret et al., 2003), and an increased number of T reg cells has been associated with poor 
clinical outcome (Venet et al., 2009). However, alternative studies have reported that in vitro 
stimulated T reg cells caused an increase in bacterial clearance and improved survival in the 
murine model of sepsis (Heuer et al., 2005).  
 
 
1.8.2 Markers of regulatory T cells  
 
Reliable surface markers are essential for the quantification of viable T regulatory 
cells. These surface and intracellular markers differentiate these cells from other CD4+ T cells. 




Upon activation all T cells express the  chain of the interleukin-2 receptor, known as CD25 
(Corthay, 2009). The up-regulation of CD25 expression has been associated with increased T 
 22 
reg function upon tumour necrosis factor (TNF) stimulation (Chen et al., 2007), which may 
suggest that higher CD25 levels are indicative of an increase in suppressive T reg cells. The co-
expression of CD4 and CD25 has also been found to define functional T reg cells within the 
peripheral blood. The utilization of CD25 as a definitive marker of T reg cells is problematic as 
it is also expressed on activated effector T cells, therefore a combination of CD25+/HIGH 
alongside other markers has been suggested in order to identify functional T regulatory cells 




FOXP3 is an intracellular transcription factor and has been termed a ‘master control gene’ 
with regards to T reg development (Safina et al., 2015). Studies have shown that the 
expression of FOXP3 is restricted to  T cells, whereas in  T cells, B cells, natural killer (NK), 
dendritic cells, and macrophages, it is almost undetectable (Corthay, 2009). The loss of FOXP3 
expression has been linked to the competency of T reg cells in acquiring certain properties 
including the production of IL-2, IL-17, IL-4, IFN- cytokines (Wan & Flavell, 2007). Based on 
studies which show that some effector cells may express FOXP3 with no associate regulatory 
activity, this marker alone cannot be deemed to be sufficient in identifying T reg cells 
(Corthay, 2009).  
 
The inverse correlation between the expression of FOXP3 and CD127, on the  chain of the 
IL-7 receptor, with respect to the suppressive capabilities of T reg cells has been reported (Liu 
et al., 2006). Therefore, a combination of CD25, FOXP3, and CD127 are considered to be the 
most sufficient markers for defining T reg cells in a research setting (Safina et al., 2015). An 
increased proportion of CD4+CD25+CD127low has also been reported in thoracic trauma 
























1.9 Study aims and objectives 
 
Currently there is little data available which assesses T lymphocyte cell surface 
markers and their role in the adaptive immune response to major trauma, which often leads 
to the onset of MODS and sepsis. As a variety of studies highlight that an imbalance between 
the SIRS and CARS responses result in an increased susceptibility to infections, analysing early 
changes in the components of these responses may be indicative of poor clinical outcomes. 
 
T regulatory cells in particular, are a component of the adaptive immune response to 
trauma which has been linked to the counter inflammatory (CARS) reaction. These cells are 
known for their suppressive abilities against immune effector cells, and are most widely 
characterised by their expression of CD4+, CD25+, FOXP3+, and CD127Low marker profiles. 
Overexpression of T reg cells may therefore indicate overactivity of the CARS response and 
act as a predictive biomarker for late onset complications secondary to trauma such as 
multiple organ failure and sepsis.  
 
In addition, although many studies have analysed cytokine expression in major trauma 
patients, few have characterised both the cytokine and T lymphocyte expression. It is 
postulated that the anergic like properties of T mediated responses result in suppressed Th1 
type cytokine production and increased T reg activity, therefore a correlation between the 
expression of pro and anti-inflammatory cytokines with T reg cells may also be indicative of 
the CARS response and act as a predictive biomarker for poor clinical outcome.  
 
Thus, the following objectives were outlined: 
 
1) To correlate immune marker (CD3+, CD4+, CD25, CD25BRI, CD4+FOXP3+, 
CD25BRIFOXP3, CD127LOWFOXP3) changes with clinical outcomes (SOFA score), via 
full data analysis and grouped SOFA analysis. 
2) To predict associations between T reg patterns and clinical outcomes.  
3) To compare pro inflammatory (IL-6) and anti-inflammatory (IL-10) cytokine changes 

















CHAPTER 2: Materials and methods 
 
 
2.1 Study designs  
 
2.1.1 Patient selection criteria  
 
A total study group of 85 major trauma patients were selected for inclusion into this 
project; 59 patients were from the Central Manchester Foundation Trust (CMFT), and the 
remaining 26 patients were from the Salford Royal Foundation Trust hospital (SRFT). All 
patients included in the study will have traumatic injuries severe enough to require intensive 
care unit admission, immediate surgery, or an injury severity score (ISS) greater than 15. As 
well, as this all patients under the age of 16 years old or on immunosuppressive medication 
were excluded from the study.   
 
2.1.2 Data collection time points  
 
Venous blood (20ml) was collected by medical staff working in the relevant hospitals 
within 24 hours of the injury. Subsequent blood samples were then collected on days 3 and 
5 following the injury. A range of additional data was also collected on days 1, 3 and 5 (Table 
2.1).  
 
Table 2.1: Data collection sheet used for Day 1, 3, and 5.  
 
DAY DATE 
HR  BP  Temp C 
Hb  WCC  PLT  
eGFR  Creatinine  Bilirubin  
PT  Intubated Y/N NIV/CPAP Y/N 
FiO2 % P/F ratio kPA Lactate mmol/L 
Noradrenaline g/kg/min CRP Mg/L CVVH/IHD Y/N 
Sedated  GCS    
Treated with 
antibiotics 
Y/N Source of sepsis  
HR: Heart rate, Hb: Haemoglobin, eGFR: estimated glomerular filtration rate, PT: Prothrombin 
time, FiO2: Fraction of inspired oxygen, BP: Blood pressure, WCC: White blood cell count, P/F 
ratio: Ratio of arterial oxygen partial pressure to fractional inspired oxygen, CRP: C-reactive 
protein, GCS: Glasgow coma scale, PLT: Platelet, NIV/CPAP: Non-invasive 
ventilation/Continuous positive airway pressure, CVVH/IHD: Continuous veno-venous 









2.2 Laboratory methods  
 
The following laboratory procedures were carried out at the University of Salford 
(Cockcroft laboratory) prior to this study by PhD student Basmah Allarakia, 2018. The 
laboratory methods have been summarised below and the data collected from these 
procedures were used during this report for significant data analysis.  
 
2.2.1 Peripheral blood mononuclear cells (PBMC) isolation and cryopreservation 
 
Firstly, 20ml of blood was added to four 10ml centrifuge tubes. These were then 
diluted in an equal volume of PBS, before overlaid onto lymphoprep at a ratio of 2:1. All 4 
tubes were then centrifuged at 1800 rpm for 20 minutes. PBMCs were found at an interface 
between lymphoprep and plasma due to the different densities of the component cells, 
therefore the PBMC rich interface was easily harvested and washed using 45ml of PBS, before 
being centrifuged at 1200 rpm for 10 minutes. Giemsa staining and microscope were then 
used to confirm cell pellets. Finally, the plasma layer was collected and divided between 1ml 
cryovials in order to be stored at -80C for further analysis.  
 
A cryopreservation media containing 10l dimethyl-sulfoxide (DMSO) and 900l fetal 
calf serum (FCS) was then used to re-suspend the PBMC pellet aliquoted in cryovials. These 
were placed into a container containing isopropanol and placed at -80C. After 24 hours, all 
vials were stored in liquid nitrogen for future analysis. 
 
2.2.2 Retrieval of PBMCs  
 
In order to check the viability of retrieved PBMCs, 1 part of trypan blue dye was mixed 
with 1 part cells and applied to a disposable haemocytometer. Total cell numbers were 
calculated using the following formula: 
 
PBMC/mL = Average number of PBMCs counted X dilution factor X 104  
 
2.2.3 PBMC enrichment  
 
200l of anticoagulant treated whole blood was added to 2ml of diluted red blood 
cells (RBC) lysing buffer, containing 9 parts distilled water and 1 part 10X RBC lysis buffer. This 
was vortexed and intubated at room temperature, in the dark for 5-10 minutes. Following 
this the lysate was centrifuged at 1800 rpm for 10 minutes, cell pellets were also re-
suspended in 2ml of diluted RBC lysis buffer, and a lysis was carried out a second time as 
mentioned above. Following centrifugation at 120 rpm for 10 minutes, cell pellets were finally 
re-suspended to 1ml of PBS and transferred into a 5ml tube for flow cytometry.  
 
20ml of whole blood was centrifuged at 3000 rpm for 5 minutes in order to obtain 
the buffy coat layer. This buffy coat was removed from an interface between plasma and 
blood and washed with RBC BD lysis buffer. Finally, cell pellets were removed and aliquoted 
in 1ml cryovials and stored at -80C. Similarly, the plasma layer was also aliquoted into 1ml 
cryovials and stored in the same manner. 
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2.2.4 Giemsa staining and microscopy  
 
Smears of PBMC preparations were fixed in methanol. 1ml of concentrated giemsa 
stain was added to 9ml of giemsa buffer solution, and the slide stained for 20 minutes. An oil 
emersion objective lens (100x) from a light microscope was used for observation.  
 
2.2.5 Immuno-fluorescent staining of T cell surface markers  
 
A 100l PBMC extract obtained in (section 2.2.3) was added to fluorochrome-labelled 
conjugated antibodies (Table 2.2). The selection of the antibody panels was dependant on the 
expression/density of antigens and the fluorochrome brightness (Table 2.3). The tubes were 
gently mixed and an additional 100l of PBS was added. All tubes were incubated at 4C for 
30 minutes and shielded from light. Cells were then washed with 1ml of PBS, before being 
centrifuged at 1800 rpm for 10 minutes. The remaining cell-pellets were resuspended in 500l 
of PBS and the supernatant was discarded.  
 
Table 2.2: Cellular antibodies  
 








Table 2.3: Antibody panel used for T reg cell staining 
 
Antibodies panel Clone Fluorescence Purpose 
CD3 UCHT1 (PerCP-Cy5) T cell subsets 
CD4 RAP-T4 (RUO) (APC-A) T cell subsets 
CD8 SK1 (APC-CY7-A) T cell subsets 
CD25 M-A251 (PE-Cy7-A) T cell activation 
T reg identification 
CD127 HIL-7R-M21 (RUO) (FITC) T reg marker 




2.2.6 Staining for FOXP3+ transcription markers 
 
The mixture of surface stained cells from (section 2.2.5) were resuspended in 1ml of 
Foxp3 fixation/permeabilization buffer, vortexed and incubated in the dark at 4C for 30-60 
minutes. 2ml of diluted permeabilization buffer was then added, followed by 5 minutes of 
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centrifugation at 1800 rpm. Cell pellets were then resuspended in 2l of 2% normal rat serum 
and 100l diluted permeabilization buffer, vortexed and incubated in the dark for 15 minutes.  
Next, 3l of anti-human FoxP3-PE was added to each tube, vortexed and incubated 
for 60 minutes. Following this, the cells were resuspended in 2ml of diluted permeabilization 
buffer and centrifuged for 5 minutes at 1800 rpm, before being resuspended in 2ml flow 
cytometry staining buffer and centrifuged once again for 5 minutes at 1800 rpm. Finally, the 
cell pellet was resuspended in 1ml of flow cytometer staining buffer.  
 
2.2.7 Flow cytometry analysis  
 
FACS Verse flow cytometry was used to analyse the samples and FACS Suite software 
was used for data analysis. Forward (FSC) versus side scatter (SSC) displays were used to 
encircle the lymphocyte region and all fluorescent parameters were gated on this population 
in order to detect specific CD receptor subsets. The results were displayed as the percentage 
of cells which fell above the negative region for each of the antibodies.  
 
2.2.8 Gating strategy  
 
Gating strategy was created using the BD FAC Suite software. This allowed 
visualisation and differentiation of lymphocytes according to their granularity and cell size. A 
gate was created around the lymphocyte region and all data analysis was restricted to this 
cell population. Further gates according to specific antibody labelled sub populations of T cells 
was done for further analysis of these subsets. The percentage of positive cells of the gate 
was recorded.  
 
 
2.3 Statistical analysis  
 
All statistical analysis was done during this study using the SPSS statistical software.  
 
2.3.1 Statistical analysis of early T cell expression and late SOFA scores  
 
Firstly, in order to explore the relationship between T lymphocytes, specifically T reg 
cells, and poor clinical outcomes, the mean T lymphocyte (CD3+, CD4+, CD8+, CD25BRI, 
CD25BRIFOXP3+, CD4+FOXP3+, and CD127LOWFOXP3+) expression on Day 1 and 3 were 
tested against mean Day 5 SOFA scores using a Spearman’s rank correlation test.  
 
A Spearman’s rank correlation test is used to analyse the relationship between two 
measurements which are not clearly unaffected by each other, when data is not normally 
distributed. Therefore, this was done in order to identify early expression of T reg cells which 






2.3.2 Statistical analysis of early T cell expression and late grouped SOFA scores 
 
In order to test the hypothesis that poor clinical outcome is linked to higher T reg 
expression, patients were separated into two groups based on their Day 5 SOFA scores.  
 
The mean T cell expression (CD3+, CD4+, CD8+, CD25BRI, CD25BRIFOXP3+, 
CD4+FOXP3+, and CD127LOWFOXP3+) on Day 1 was then tested against group 1 and then 
group 2. A paired T test was used as the statistical test as it effectively highlights significant 
differences between measurements which are in matched pairs, such as SOFA <1 and SOFA 
>1 in this case.  
 
 
2.3.3 Statistical analysis of T cell and interleukin expression  
 
In order to explore the relationship between T cell expression, particularly T reg cells, 
and other mediators of inflammation, all CD markers on Day 1 were tested against interleukin 
6 and interleukin 10 also on Day 1, 3, and 5. 
 
Similar to section (2.3.1), a Spearman’s rank correlation test was the statistical test 
chosen for this analysis in order to explore relationships between two measurements which 


















CHAPTER 3: Results 
 
3.1 Trends in T cell subset expression on Day 1, 3, and 5 following traumatic injury.  
 
A study group of 85 patients consented to provide T cell subset expression data for 
this study. On Day 1 the maximum data from all 85 patients was obtained. On Day 3, this 
reduced to 80, and on Day 5 reduced further to 76, due to deceased and discharged patients. 
The trends of T cell expression on all of these days were displayed by obtaining the average 
(mean) expression on each day for each subset, the results of which are displayed in a simple 
column graph (Figure 3.1).  
 
As expected the CD4+/CD8+ ratio, an indicator of immune activity, continues to 
increase from day 1 to 5 (0.62, 0.65, and 0.68 respectively). Both CD125BRIFOXP3+ and 
CD127LOWFOXP3+, which are known to be efficient markers of T reg cells displayed similar 
trends as a decrease in expression is seen from Day 1 to 3 followed by a further increase on 




Figure 3.1: Trends in T cell subset expression on Day 1, 3, and 5 following traumatic injury. 

























































































Average T cell subset expression on Day 1, Day 3, and Day 






3.2 Relationships between mean T cell data and SOFA scores.  
 
A maximum study group of 85 major trauma patients were selected for inclusion into 
this project; 59 patients were from the Central Manchester Foundation Trust (CMFT), and the 
remaining 26 patients were from the Salford Royal Foundation Trust hospital (SRFT). On Day 
1 patient cohort size for tests against CD3+, CD4+, CD8+, CD25BRI, CD25BRIFOXP3+, and 
CD4+FOXP3+ was 85. However, for CD127LOWFOXP3+ analysis, patient cohort was 74, 
consisting of 48 CMFT and 26 SRFT patients. This was due to incomplete CD127LOWFOXP3+ 
expression data from CMFT patients. On Day 3, due to death or discharge of additional 
patients, overall cohort size was 80, consisting of 56 CMFT patients and 24 SRFT patients. 
Once again, CD127LOWFOXP3+ patient cohort was lower at a total of 70; 46 from CMFT and 
24 from SRFT.  
As presented in (Table 1.2), the overall SOFA score was calculated for each patient on 
Day 1, 3, and 5 following injury,  composing of SOFA scores from all six organs, with the 
maximum score possible being 24.  
 
In order to test the hypothesis that T reg cells are involved in the immune response 
which may result in a poor clinical outcome, a Spearman’s correlation test was done using 
SPSS Statistical software in order to identify relationships between average patient CD values 
(CD3+, CD4+, CD8+, CD25BRI, CD25BRIFOXP3+, CD4+FOXP3+, CD127LOWFOXP3+) on Day 1 
and their SOFA scores on DAY 5 following injury. This was also done for each CD marker on 
DAY 3 against SOFA scores on DAY 5 (Figure 3.1, - 3.7). The results of this may allow 
identification of useful markers whose expression on Day 1 or 3 following injury may be 
indicative of clinical outcomes on Day 5, represented by SOFA scores.  
 
A Spearman’s correlation test showed that there is a significant relationship between 
patient CD3+ levels on Day 1 and their SOFA scores on Day 5 (p=0.007), as well as CD3+ on 
Day 3 and SOFA scores on Day 5 (p=0.02). All other CD markers on Day 1 failed to display any 
significant relationship to Day 5 SOFA scores. However, both CD25BRIFOXP3+ and 
CD127LOWFOXP3+ displayed significant relationships on Day 3 when tested against Day 5 

































Figure 3.1:  (A) Simple scatter displaying the average CD3+ values on Day 1 following 
traumatic injury against SOFA scores on Day 5 (n=85). (B) Simple scatter displaying the 
average CD3+ values on DAY 3 following injury against SOFA scores on DAY 5 (n=80). 
(Spearman’s correlation was carried out to find relationship between Day 1 CD3+ and Day 5 



















Figure 3.2:  (A) Simple scatter displaying the average CD4+ values on Day 1 following 
traumatic injury against SOFA scores on Day 5 (n=85). (B) Simple scatter displaying the 
average CD4+ values on DAY 3 following injury against SOFA scores on DAY 5 (n=80). 
(Spearman’s correlation was carried out to find relationship between Day 1 CD4+ and Day 5 
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Average patient CD3+ on Day 1 

















Average CD3+ on Day 3
Average patient CD3+ on Day 3 
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Average CD4+ on Day 3
Average patient CD4+ on Day 3 







Figure 3.3:  (A) Simple scatter displaying the average CD8+ values on Day 1 following 
traumatic injury against SOFA scores on Day 5 (n=85). (B) Simple scatter displaying the 
average CD8+ values on DAY 3 following injury against SOFA scores on DAY 5 (n=80). 
(Spearman’s correlation was carried out to find relationship between Day 1 CD8+ and Day 5  




















Figure 3.4:  (A) Simple scatter displaying the average CD25BRI values on Day 1 following 
traumatic injury against SOFA scores on Day 5 (n=85). (B) Simple scatter displaying the 
average CD25BRI values on DAY 3 following injury against SOFA scores on DAY 5 (n=80). 
(Spearman’s correlation was carried out to find relationship between Day 1 CD25BRI and Day 


















Average CD8+ on Day 1
Average patient CD8+ on Day 1 

















Average CD8+ on Day 3
Average patient CD8+ on Day 3 
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Average patient CD25BRI on Day 1 

















Average CD25BRI on Day 3
Average patient CD25BRI on Day 3 



















Figure 3.5:  (A) Simple scatter displaying the average CD25BRIFOXP3+ values on Day 1 
following traumatic injury against SOFA scores on Day 5 (n=85). (B) Simple scatter displaying 
the average CD25BRIFOXP3+ values on DAY 3 following injury against SOFA scores on DAY 
5 (n=80). 
(Spearman’s correlation was carried out to find relationship between Day 1 CD25BRIFOXP3+ 
and Day 5 SOFA, as well as Day 3 CD25BRIFOXP3+  and Day 5 SOFA. (Part A; p=0.861) (Part B; 




















Figure 3.6:  (A) Simple scatter displaying the average CD4+FOXP3+ values on Day 1 following 
traumatic injury against SOFA scores on Day 5 (n=85). (B) Simple scatter displaying the 
average CD4+FOXP3+ values on DAY 3 following injury against SOFA scores on DAY 5 (n=80). 
(Spearman’s correlation was carried out to find relationship between Day 1 CD4+FOXP3+ and 
Day 5 SOFA, as well as Day 3 CD4+FOXP3+  and Day 5 SOFA. (Part A; p=0.147) (Part B; p= 
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Average CD25BRIFOXP3+ on Day 3
Average patient CD25BRIFOXP3+ on 
Day 3 following injury against SOFA 
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Average CD4+FOXP3+ on Day 3
Average patient CD4+FOXP3+ on Day 3 




















Figure 3.7:  (A) Simple scatter displaying the average CD127LOWFOXP3+ values on Day 1 
following traumatic injury against SOFA scores on Day 5 (n=74). (B) Simple scatter displaying 
the average CD127LOWFOXP3+ values on DAY 3 following injury against SOFA scores on 
DAY 5 (n=70). 
(Spearman’s correlation was carried out to find relationship between Day 1 
CD127LOWFOXP3+ and Day 5 SOFA, as well as Day 3 CD127LOWFOXP3+  and Day 5 SOFA. 





Table 3.1: Summary of p values generated from a Spearman’s correlation test in order to 
test relationships between average CD values on day 1 and 3 against SOFA scores on Day 5. 
 
 
DAY 1 CD VS DAY 5 SOFA 
(P value) Sig 




CD3+ 0.007 ** 0.02 * 
CD4+ 0.257   0.474  
CD8+ 0.215   0.152  
CD25BRI 0.775   0.665  
CD4+FOXP3+ 0.147   0.963  
CD25BRIFOXP3 0.861  0.049 * 
CD127LOWFOXP3 0.637  0.048 * 
 
Sig = Significance  
*= Correlation is significant at the 0.05 level 
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Average CD127LOWFOXP3+ on Day 3
Average patient CD127LOWFOXP3+ on 
Day 3 following injury against SOFA 






3.3 Relationship between mean T cell data and grouped SOFA scores  
 
In order to test the hypothesis that higher expression of T reg cells are seen in patients 
with poorer clinical outcome, patients were separated into two groups; those with SOFA 
scores less than 1 on Day 5, and those with SOFA scores greater than 1 on Day 5. The mean 
CD marker expression on Day 1 of each patient were then tested against the two groups of 
Day 5 SOFA scores. Group 1 consisted of 38 patients; 34 from CMFT and 4 from SRFT, all with 
a Day 5 SOFA score of 0. Group 2 consisted of 43 patients; 23 from CMFT and 20 from SRFT, 
with Day 5 SOFA scores ranging from 1 to 12. A paired T test was used to highlight any 
significant differences. 
 
In the case of the CD markers CD3+, CD4+, CD25BRI, and CD4+FOXP3+, a lower 
expression was seen on Day 1 for those patients which displayed SOFA scores greater than 1 
on Day 5 (Figures 3.8 – 3.11). However, a paired T test highlighted that none of these 
differences were significant (p=0.052, p=0.550, p=0.173, and p=0.278 respectively). 
Alternatively, CD8+, CD25BRIFOXP3, and CD127LOWFOXP3 displayed higher expression on 
Day 1 for those patients which displayed SOFA scores greater than 1 on Day 5 (Figures 3.12 – 
3.14). As anticipated, a paired T test highlighted that this was statistically significant for 









Figure 3.8: Simple histogram comparing mean CD3+ on Day 1 for patients with a SOFA score 
of less than 1 with patients with a SOFA score greater than 1 on Day 5.  









Figure 3.9: Simple histogram comparing mean CD4+ on Day 1 for patients with a SOFA score 
of less than 1 with patients with a SOFA score greater than 1 on Day 5.  







Figure 3.10: Simple histogram comparing mean CD25BRI on Day 1 for patients with a SOFA 
score of less than 1 with patients with a SOFA score greater than 1 on Day 5.  







Figure 3.11: Simple histogram comparing mean CD4+FOXP3+ on Day 1 for patients with a 
SOFA score of less than 1 with patients with a SOFA score greater than 1 on Day 5.  







Figure 3.12: Simple histogram comparing mean CD8+ on Day 1 for patients with a SOFA 
score of less than 1 with patients with a SOFA score greater than 1 on Day 5.  









Figure 3.13: Simple histogram comparing mean CD25BRIFOXP3+ on Day 1 for patients with 
a SOFA score of less than 1 with patients with a SOFA score greater than 1 on Day 5.  







Figure 3.14: Simple histogram comparing mean CD127LOWFOXP3+ on Day 1 for patients 
with a SOFA score of less than 1 with patients with a SOFA score greater than 1 on Day 5.  











Table 3.2: Summary of difference in mean Day 1 T cell expression between patients with a 




on Day 1 when Day 
5 SOFA is <1 
Average expression 
on Day 1 when Day 
5 SOFA is >1 
Sig 
CD3+ 66.64 60.92  
CD4+ 60.50 59.27  
CD25BRI 20.32 18.75  
CD4+FOXP3+ 13.11 10.87  
CD8+ 35.02 36.59  
CD25BRIFOXP3+ 81.94 87.04 * 
CD127LOWFOXP3+ 76.35 87.38 ** 
 
Sig = Significance  
*= Difference is significant at the 0.05 level 



























3.4 Relationship between T cell data and Interleukin 6 (IL-6) and interleukin 10 (IL-10).  
 
In order to explore the relationship between CD markers, particularly T reg cells, and 
other mediators of inflammation, all CD markers used in this study (CD3+, CD4+, CD8+, 
CD25BRI, CD25BRIFOXP3+, CD4+FOXP3+, and CD127LOWFOXP3+), were tested against 
interleukin 6 (IL-6) and interleukin 10 (IL-10).  
 
A study group of 60 patients was used and IL-6 and IL-10 expression was determined 
on Day 1, 3, and 5 following injury. A Spearman’s rank correlation was done on Day 3 in order 
to identify any relationships between IL-6 and T reg cells , as well as IL-10 and T reg cells. For 
Day 1 analysis of CD markers against IL-6 and IL-10, patient cohort size was 60; 41 from CMFT 
and 19 from SRFT. This was reduced to 52 on Day 3; 40 from CMFT and 12 from SRFT due to 
incomplete patient records. Finally, it was increased on Day 5 again to 59; 41 from CMFT and 
18 from SRFT due to one death.  
 
 
Interestingly, significant correlations were only seen between T reg markers and  
interleukins on Day 3, similar to results seen in section (3.1) between Day 3 T regs and Day 5 
SOFA scores. A Spearman’s rank correlation test showed that there is a significant relationship 
between patient CD3+ and IL-10 levels on Day 3 (p-0.000) (Figure 3.15 (B)). All other CD 
markers failed to display any significant relationship to IL-10. However, as expected both 
CD25BRIFOXP3+ and CD127LOWFOXP3+ T reg cells displayed significant relationships on Day 



















Figure 3.15: (A) Simple scatter displaying the relationship between average CD3+ expression 
against average IL-6 expression on Day 3 following injury (n=52). (B) Simple scatter 
displaying the relationship between average CD3+ expression against average IL-10 
expression on Day 3 following injury (n=52). 
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Figure 3.16: (A) Simple scatter displaying the relationship between average CD4+ expression 
against average IL-6 expression on Day 3 following injury (n=52). (B) Simple scatter 
displaying the relationship between average CD4+ expression against average IL-10 
expression on Day 3 following injury (n=52). 



















Figure 3.17: (A) Simple scatter displaying the relationship between average CD8+ expression 
against average IL-6 expression on Day 3 following injury (n=52). (B) Simple scatter 
displaying the relationship between average CD8+ expression against average IL-10 
expression on Day 3 following injury (n=52). 
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Figure 3.18: (A) Simple scatter displaying the relationship between average CD25BRI 
expression against average IL-6 expression on Day 3 following injury (n=52). (B) Simple 
scatter displaying the relationship between average CD25BRI expression against average IL-
10 expression on Day 3 following injury (n=52). 

















Figure 3.19: (A) Simple scatter displaying the relationship between average CD25BRIFOXP3+ 
expression against average IL-6 expression on Day 3 following injury (n=52). (B) Simple 
scatter displaying the relationship between average CD25BRIFOXP3+ expression against 
average IL-10 expression on Day 3 following injury (n=52). 























Average CD25BRI on Day 3
Average patient CD25BRI against 






















Average CD25BRI on Day 3
Average patient CD25BRI against IL-10 




















Average CD25BRIFOXP3+ on Day 3
Average patient CD25BRIFOXP3+ 























Average CD25BRIFOXP3+ on Day 3
Average patient CD25BRIFOXP3+ against 

















Figure 3.20: (A) Simple scatter displaying the relationship between average CD4+FOXP3+ 
expression against average IL-6 expression on Day 3 following injury (n=52). (B) Simple 
scatter displaying the relationship between average CD4+FOXP3+ expression against 
average IL-10 expression on Day 3 following injury (n=52). 




















Figure 3.21: (A) Simple scatter displaying the relationship between average 
CD127LOWFOX3+ expression against average IL-6 expression on Day 3 following injury 
(n=45). (B) Simple scatter displaying the relationship between average CD127LOWFOXP3+ 
expression against average IL-10 expression on Day 3 following injury (n-45). 
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Table 3.2: Summary of p values generated from a Spearman’s rank correlation test in order 
to test relationships between average CD expression with average IL-6 and IL-10 expression 
on Day 3.  
 
 
DAY 3 CD VS DAY 3 IL-6 
(P value) Sig 




CD3+ 0.308  0.000 ** 
CD4+ 0.933   0.877  
CD8+ 0.581   0.410  
CD25BRI 0.200   0.277  
CD4+FOXP3+ 0.083   0.535  
CD25BRIFOXP3 0.026 * 0.113  
CD127LOWFOXP3 0.029 * 0.155  
 
Sig = Significance  
*= Correlation is significant at the 0.05 level 


















4.1 Trends in T lymphocyte expression following traumatic injury  
 
Major traumatic injury is responsible for initiating a complex immunosuppressive 
response which is often associated with late multiple organ dysfunction syndrome (MODS) or 
opportunistic infections. Following the initial response to traumatic injury, cells of the innate 
and adaptive immune system initiate the proinflammatory (SIRS) response as well as a 
counter inflammatory response (CARS) in order to restore immune homeostasis (Stoecklein 
et al., 2012). Multiple organ dysfunction syndrome (MODS) accounts for a large fraction of 
the healthcare resources related to acute trauma care. It is often associated with poor clinical 
outcomes as it is common among critically injured patients who may survive the initial trauma 
(Cole et al., 2019). Early identification and prevention of MODS would therefore allow a large 
reduction in late phase mortality due to trauma. The first objective of this chapter aims to 
discuss the trends in T lymphocyte expression following traumatic injury.  
 
One indicator of immune function is the CD4+/CD8+ ratio, with a ratio of less than 1 
being associated with biomarkers of inflammation in studies assessing HIV therapies (Davy-
Mendez et al., 2018). As shown in (Figure 3.1) the expression of CD4+ continued to increase 
from Day 1 to 5 following traumatic injury, whereas CD8+ expression continued to decrease. 
An elevated CD4+/CD8+ ratio was observed as a result of this (0.62, 0.65, 0.68), indicating 
elevated immunoactivity on each day following injury. The total lymphocyte count of CD4+ 
on Day 1, 3, and 5 following injury displayed an increasing trend. These findings are consistent 
with previous work which highlighted a rise of T cell populations in mice exposed to trauma 
(Rani & Schwacha, 2017). Alternatively, the decrease in CD8+ from day 1, 3, and 5, correlates 
to previous studies which proposed that the reduction in CD8+ T cells in major trauma 
patients may compromise their ability to establish an effective response to pathogens as well 
as enhancing their susceptibility to infectious disease (Sommershof et al., 2009). 
 
 Interestingly, trends in expression were also seen in CD4+FOXP3+, CD25BRIFOXP3, 
and CD127LOWFOXP3+, all of which have been recognised as effective markers of T reg cells. 
Studies have previously highlighted the role of T reg cells during traumatic injury due to their 
suppressive abilities. In the case of sepsis, circulating T regs from trauma patients displayed 
increased T reg cell activity by 5-7 days following injury, in comparison with T reg cells from 
normal individuals or patients at day 1 following injury (MacConmara et al., 2006). This is also 
highlighted in Figure 3.1 by CD4+FOXP3+, CD25BRIFOXP3+ and CD127LOWFOXP3+ as 
expression is elevated on Day 5 following injury.  
 
The overall trend seen by CD25BRIFOXP3+ and CD127LOWFOXP3+ was an increase in 
expression from Day 1 to Day 5 following injury, however, a decrease was seen on Day 3 prior 
to the increase on Day 5. CD25BRIFOXP3+ expression initially decreased from Day 1 to Day 3 
(N= 86.57, N= 82.96 respectively), as was the case for CD127LOWFOXP3+ (N= 86.39, N=84.27). 
This may correlate to studies done to analyse regulatory T cell dynamics following porcine 
polytrauma. In a study which analysed 20 peripheral blood samples with an injury severity 
score >16 on Day 1 and Day 3 following admittance, a comparable decrease in T reg cells was 
seen early after polytrauma (Serve et al., 2018).  
4.2 Comparison of early T lymphocyte subsets in relation to late SOFA scores  
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The second objective of this study aims to display that the development of MODS and 
poor clinical outcome following major trauma results from the immunosuppressive CARS 
response, in particular T reg cells, causing increased patient susceptibility to opportunistic 
infections. As described in previous chapters, the Sequential Organ Failure Assessment (SOFA) 
is an approved scoring system which allows the identification of MODS. The collection of SOFA 
scores on Day 1, 3, and 5 following traumatic injury allowed for this study to use SOFA scores 
as an indicator of poor clinical outcome. Early trends in T lymphocyte subsets in relation to 
late SOFA scores were analysed in order to identify early T cell marker changes which may be 
indicative of late SOFA predictions. This may therefore be used as a diagnostic tool to identify 
poor clinical outcomes from a cohort of high risk patients.  
 
As described in previous chapters, the counter anti-inflammatory response (CARS) to 
trauma acts in response to inflammation, in order to restore immune homeostasis. It has been 
labelled as an immune suppressive response due to the anergic like properties displayed by 
the T cell mediated response it entails. These include low proliferative responses to specific 
antigens; suppressed Th1 type immune reactivity alongside increased Th2 type cytokine 
production; finally increased T reg activity (Stoecklein et al., 2012). Therefore, a primary 
complication of the CARS response is that it may actively suppress antimicrobial immunity, 
thus increasing the hosts susceptibility to opportunistic infections (Osuka et al., 2014). The 
work of T reg cells in particular during this CARS response has been an area of debate over 
the years.  
 
During this study, a relationship between CD25BRIFOXP3+ on Day 3 and SOFA scores 
on Day 5 was found to be significant (p= 0.049), as was also the case for CD127LOWFOXP3+ 
on Day 3 and SOFA on Day 5 (p= 0.048). Interestingly, all other T regulatory subsets failed to 
show any significant relationship to Day 5 SOFA scores. This may be explained by extensive 
studies which have highlighted that a combination of CD25, FOXP3, and CD127 are considered 
to be the most sufficient markers for defining T reg cells in a research setting (Safina et al., 
2015). The up regulation of CD25 expression previously associated with increased T 
regulatory cell function upon TNF stimulation (Chen et al., 2007), may suggest that higher 
CD25 levels are indicative of an increase in suppressive T reg cells. However, CD25 alone has 
proven to be problematic, therefore a combination of CD25+ alongside other markers is 
preferred. This may explain the lack of significance seen when examining relationships 
between CD25BRI on Day 3 and SOFA on day 5 (p= 0.665). Similarly, CD4+FOXP3+ alone on 
Day 3 also displayed no significant relationship with Day 5 SOFA (p= 0.963), as predicted due 
to previous research highlighting that this marker alone cannot be deemed sufficient in 
identifying T regulatory cells (Corthay, 2009).  
 
The only marker which displayed a significant relationship on both Day 1 and 3 to SOFA 
scores on Day 5 was CD3+ (p= 0.007 and p= 0.02 respectively). This correlates to the work of 
Rani and Schwacha who found an influx of CD3+ T cells into the wound site of a burn injury. 
Furthermore, in normal skin, only 6.8% of cells were found to be CD3+, whereas skin cells 
within a burn wound were found to be 24% CD3+ T cells (Rani & Schwacha, 2017).  
 
The relationship seen between Day 3 CD25BRIFOXP3+ and CD127LOWFOXP3+ against 
Day 5 SOFA may be explained due to the known suppressive ability of T regulatory cells, which 
will ultimately affect clinical outcome, represented in this study by patient SOFA scores. 
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However, the extent of this relationship cannot be determined without clear categorisation 
of SOFA scores. In order to do this, the patient cohort was split into two groups. Group 1 
consisted of 38 patients, all with a Day 5 SOFA score of 0, whereas group 2 consisted of 43 
patients with Day 5 SOFA scores ranging from 1 to 12. The average (mean) expression of T 
lymphocytes on Day 1 between these two groups was then analysed using a paired T test.  
 
The average (mean) expression of CD25BRIFOXP3+ on Day 1 for patients with a Day 5 
SOFA score of less than 1 was found to be 81.94, however, this expression was 87.04 on Day 
1 for patients with a Day 5 SOFA score greater than 1. As expected, this difference was found 
to be significant (p= 0.05). Similarly, the average expression of CD127LOWFOXP3+ on Day 1 
for patients with a Day 5 SOFA score of less than 1 was found to be 76.35, which is seen to 
increase to 87.38 for patients with a Day 5 SOFA score greater than 1. Once again, this 
difference was found to be significant (p= 0.03). These results correlate with the previous 
studies which describe the role of T regulatory cells and their suppression of the immune 
responses. Some examples of this include; higher numbers of circulating T regs found in septic 
patients (Monneret et al., 2003), or the direct association of increased T reg numbers with 
poor clinical outcome (Venet et al., 2008). In addition, T reg cells have been found to inhibit 
the activation and proliferation of CD8+ and CD4+ T cells in TCR signals, as well as inhibit B 
lymphocytes, neutrophils, dendritic cells, and monocytes/macrophages (Cao et al., 2015). It 
is findings such as these which may explain the significant increase in CD25BRIFOXP3+ and 
CD127LOWFOXP3+ expression on Day 1 for patients who later developed higher SOFA scores 
(>1), and therefore a poorer clinical outcome.  
 
The suppression mechanisms of T regs which may explain these results have been 
grouped into four main categories, these are; suppression by metabolic disruption, 
suppression by cytolysis, suppression by inhibitory cytokines such as interleukin-35 (IL-35), IL-
10, and transforming growth factor- (TGF-), and finally, suppression by modulation of 
dendritic cell function or maturation (Cao et al., 2015).  
 
Investigations into the effects of traumatic injury on T reg cells has displayed that an 
increased expression of costimulatory molecules such as CTLA-4, PD-1, ICOS, and CD28, is 
indicative of increased T reg survival or function. In particular an increase in CTLA-4 expression 
by T reg cells 7 days following traumatic injury may suppress APC function via an IDO 
mechanism, resulting in an increase in T reg potency. Alternatively, T cell activation may be 
suppressed by blocking CD80 and CD86 access to CD28 (Stoecklein et al., 2012).  
 
During the disruption of metabolic pathways, enzymes expressed on T reg cells such 
as CD39 and CD73, cause the metabolism of ATP to AMP, resulting in the production of  
immunoregulatory adenosine. T regs also express high levels of intracellular cAMP which is 
transferred to T effector cells, resulting in the inhibition of nuclear factor of activated T cells 
(NFAT) and Il-2 transcription. This disruption leads to apoptosis due to Il-2 deprivation (Safina 
et al., 2015). 
 
The final mechanism of T reg suppression is the induction of apoptosis. T reg cells are 
able to directly induce apoptosis via granzyme A/B and perforin, the Fas-ligand pathway, the 
falectin-9/TIM-3 pathway, and tumour necrosis factor related apoptosis inducing ligand 
(TRAIL) (Safina et al., 2015).  
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These mechanisms of suppression still remain poorly understood and are an area of 
ongoing research. However, several biological features of T reg cells may suggest their role in 
the control of the adaptive immune response to injury, specifically the CARS response. Their 
ability to suppress CD4+ T cell proliferation and activation firstly suggests that they may drive 
the suppression of Th1 type response (Stoecklein et al., 2012), which supports the significant 
correlation seen in this study between T regs and increased SOFA scores.  
 
The average expression of CD8+ on Day 1 was also found to be higher in patients who 
went on to develop a SOFA score greater than 1 on Day 5 (Table 3.2), however, following 
statistical analysis this was not found to be significant (p= 0.332). All other T lymphocytes 
(CD3+, CD4+, CD25BRI, and CD4+FOXP3+) displayed lower average expression on Day 1 in 
those patients who went on to develop a SOFA score greater than 1 on Day 5, however these 
were also not significant (p=0.052, 0.550, 0.173, and 0.278 respectively). 
 
4.3 Correlation between T reg cells and IL-6 and IL-10 
 
The final objective of this study aims to highlight the role of T regulatory cells in the 
suppression of T cell activation and cytokine production following traumatic injury. Various 
clinical evidence displays that the increased susceptibility of trauma patients to infections can 
be attributed in part to the reduced Th1 type immune responses and an increased counter 
inflammatory Th2 response (MacConmara et al., 2006). T regulatory cells in particular are 
thought to control these inappropriate T cell responses via the suppression of CD4+ T cell 
reactivity to antigens. T reg cells have been found to suppress the Th1 type immune response 
and promote that shift to Th2 responses, increasing patient susceptibility to infection 
(MacConmara et al., 2006). In order to explore this role of T reg cells, T lymphocytes used in 
this study were tested against IL-6 and IL-10 in order to identify any relationships between T 
reg cells in particular and these key cytokines.  
 
A Spearman’s rank correlation found a significant correlation between 
CD25BRIFOXP3+ and IL-6 on Day 3 following injury (p= 0.026). Similarly, CD127LOWFOXP3+ 
and IL-6 on Day 3 also displayed a significant correlation (p= 0.029). IL-6 is described as a 
soluble mediator which has a pleiotropic effect on inflammation, haematopoiesis, and 
immune response (Tanaka et al., 2014). Previously, IL-6 was thought to be responsible for 
regulating the Th17/T reg balance. Specifically, it was found to support the development of 
Th17, and suppress the generation of T reg cells (Bettelli et al., 2006). However, this was 
challenged when the T reg enhancing effects of IL-6 were described in both mice and humans 
(Nakagawa et al., 2010). In addition, IL-6 has been shown to be required for the induction of 
the anti-inflammatory cytokine IL-10 by T reg cells (Stumhofer et al., 2007) and 
overexpression of IL-6 was found to increase the number of T reg cells, rather than impairing 
their function (Fujimoto et al., 2011). Most recently, studies have found that contrary to 
previous research, IL-6 does not in fact inhibit the development or function of T reg cells. 
Alternatively, it enhances T effector cell activation, rendering them resistant to T regulatory 
mediated suppression (Nish et al., 2014).  
 
These more recent findings correlate with the findings of this study and may explain 
why the average expression of both T reg CD25BRIFOXP3+ and CD127LOWFOXP3+ showed 
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significant correlation to the expression of IL-6. Although previous studies may have 
suggested that this correlation is due to the suppression of T reg generation caused by IL-6, 
the work done since then suggests that this correlation may be due to the role of IL-6 in the 
resistance of T effector cells to T reg mediated suppression.  
 
A Spearman’s rank correlation also found a significant correlation between CD3+ and 
IL-10 on Day 3 following traumatic injury (p= 0.000). IL-10 is described as one of the vital anti-
inflammatory cytokines due to its ability to decrease the production of inflammatory 
molecules such as IL-12, TNF-, IFN-, major histocompatibility complex molecules, reactive 
nitric oxide metabolites, as well as its ability to inhibit antigen specific CD8+ T cells (Zeng et 
al., 2009). Elevated IL-10 has also been found in patients following trauma (Neidhardt et al., 
1997) and has been correlated with the development of sepsis (Maier et al., 2007). The 
correlation between CD3+ T lymphocytes and IL-10 can therefore be explained due to the 
inhibitory effect of IL-10 on T cell proliferation and activation. This is shown to occur through 
the disruption of IL-2 production and IFN- action, resulting in the suppression of macrophage 






In conclusion, this study confirmed a number of objectives which have previously been 
described regarding the role of T reg cells following major traumatic injury. Firstly, the 
increased expression of T reg cells seen from Day 1 to Day 5 following trauma confirm that 
the increase in T reg activity previously discovered in major trauma patients may be due to 
their involvement in the adaptive immune response.  
 
Further findings such as the significant correlation between T regulatory cells on Day 
3 and SOFA scores on Day 5, as well as a higher expression of T reg cells on Day 1 in those 
patients who developed a SOFA score of >1 on Day 5, highlighted the ability of T reg cells to 
be used as predictive biomarkers of poor clinical outcome. In particular, CD25BRIFOXP3+ and 
CD127LOWFOXP3+ displayed the most potential for this, correlating to previous research 
which states the inability of FOXP3 and CD25BRI alone to act as sufficient markers of T reg 
cells.  
 
The roles of IL-6 and IL-10 in relation to T reg cells was also explored briefly and 
revisited the debate regarding IL-6 effects on T reg cells. A significant correlation between IL-
6 and both CD25BRIFOXP3+ and CD127LOWFOXP3 on Day 3 agrees with recent research 
describing the ability of IL-6 to enhance T effector cell activation, rendering them resistant to 
T reg mediated suppression. Interestingly, no correlation was displayed between IL-10 and 
CD25BRIFOXP3+ or CD127LOWFOXP3+, despite the known suppressive abilities of all three. 
This may be explained due to the small cohort size of 52 patients involved in IL-10 analysis as 
well as the limited statistical analysis carried out on IL-10 during this study.  
 
It must finally be noted that although the interpretation of data presented in this study 
is promising and may potentially lead to the development of an improved management and 
therefore improved outcomes among major trauma patients, it must be further validated 
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using a larger cohort group. The present study, analysed a cohort of 85 patients from the 
Central Manchester Foundation Trust (CMFT) and Salford Royal Foundation Trust (SRFT), 
however a larger cohort of patients from these institutions may provide a clearer indication 
of the significance of the findings and potentially lead to further progress in the search for 
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CHAPTER 6: Appendices 
 






























































































































Appendix 9: Day 5 – T lymphocytes (CD3+, CD4+, CD8+, CD25BRI, CD25BRIFOXP3+, CD4+FOXP3+, CD127LOWFOXP3+) concentration 









Appendix 10: Day 1 and Day 3 – Average IL-6 and IL-10 concentration
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